Chemoinformaics analysis of 9-Dehydrohecogenin
| Molecular Weight | 428.613 | nRot | 0 |
| Heavy Atom Molecular Weight | 388.293 | nRig | 31 |
| Exact Molecular Weight | 428.293 | nRing | 6 |
| Solubility: LogS | -4.47 | nHRing | 2 |
| Solubility: LogP | 4.514 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 74.9697 |
| nHD | 1 | BPOL | 44.4683 |
| QED | 0.55 |
| Synth | 5.644 |
| Natural Product Likeliness | 3.342 |
| NR-PPAR-gamma | 0.86 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.904 |
| Pgp-sub | 0.997 |
| HIA | 0.007 |
| CACO-2 | -4.867 |
| MDCK | 0.0000108 |
| BBB | 0.785 |
| PPB | 0.829173 |
| VDSS | 2.041 |
| FU | 0.0398583 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.693 |
| CYP2c19-inh | 0.076 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.019 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.074 |
| CYP3a4-inh | 0.895 |
| CYP3a4-sub | 0.72 |
| CL | 17.073 |
| T12 | 0.223 |
| hERG | 0.584 |
| Ames | 0.05 |
| ROA | 0.755 |
| SkinSen | 0.948 |
| Carcinogencity | 0.727 |
| EI | 0.308 |
| Respiratory | 0.99 |
| NR-Aromatase | 0.164 |
| Antiviral | Yes |
| Prediction | 0.777202 |